Business Context and Reporting Period
This Form 8-K, filed on January 21, 2005, by WellPoint, Inc. (now Elevance Health, Inc.), reports the termination of a material definitive agreement. The filing details the constructive termination of Leonard D. Schaeffer, Chairman of the Board, effective January 31, 2005, following the November 30, 2004 merger of WellPoint Health Networks Inc. with Anthem Holding Corp.
Key Financial Metrics
The filing discloses specific compensation and severance payments triggered by the executive's termination. It does not report general corporate revenue, profit, or cash flow metrics.
- Total Cash Payment for Termination: Approximately $49,360,000.
- Deferred Compensation Lump Sum Distribution: Approximately $69,210,000 (as of January 20, 2005).
- Equity Vesting: Immediate vesting of 571,804 unvested stock options and 35,875 shares of restricted stock.
Material Changes and Payment Breakdown
The primary material change is the departure of the Chairman and the associated financial obligations. The $49,360,000 cash payment attributable to the merger and constructive termination is composed of:
- Guaranteed Annual Bonus (2004): $5,860,000.
- Cash Portion of Change in Control (CIC) Severance: $34,100,000.
- Additional SERP Amount (Age and Service Credits): $9,400,000.
Additionally, Mr. Schaeffer is receiving a lump sum distribution of his deferred compensation balances totaling $69,210,000, broken down as:
- Combined Predecessor and 2005 Plan Balance: $30,710,000.
- Schaeffer SERP Balance (excluding additional credits): $38,500,000.
Outlook, Risks, and Management Commentary
Management Commentary: The Corporation does not believe Mr. Schaeffer is subject to an excise tax under Internal Revenue Code Section 4999, though a tax gross-up provision exists in the agreement if such a tax is deemed applicable. Mr. Schaeffer has agreed not to exercise vested options except in accordance with the original exercise schedule.
Risks and Contingencies: The filing references compliance with Internal Revenue Code Section 409A regarding deferred compensation plans. The company elected to distribute the deferred compensation balance in cash rather than in Corporation Common Stock.
Investor Verification Checklist
- Verify the total cash outflow of approximately $118.57 million ($49.36M severance + $69.21M deferred distribution) impacting the company's liquidity.
- Confirm the immediate vesting of 571,804 stock options and 35,875 restricted shares and their potential dilution impact.
- Review the company's succession plan for the Chairman of the Board role following Mr. Schaeffer's departure.
- Assess the impact of the $34.1 million CIC severance payment on the company's short-term cash flow.